Goldman Sachs Group »

Akero Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 613k 23.35
2023-09-30 $17M 331k 50.58
2023-06-30 $9.8M 209k 46.69
2023-03-31 $8.5M 223k 38.26
2022-12-31 $10M 186k 54.80
2022-06-30 $18M 1.9M 9.45
2022-03-31 $16M 1.1M 14.19
2021-12-31 $37M 1.8M 21.15
2021-09-30 $697k 31k 22.36
2021-03-31 $6.1M 209k 29.01
2020-12-31 $6.7M 260k 25.80
2020-09-30 $2.2M 72k 30.80
2020-06-30 $1.8M 71k 24.93
2019-12-31 $819k 37k 22.20
2019-09-30 $594k 26k 22.74
2019-06-30 $1.1M 58k 19.15